Skip to main content
logo
Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
16.20
-0.35 (-2.11%)
Feb 10, 2026, 5:29 PM CET

Corline Biomedical AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
8.8817.2735.5232.5917.1915.08
Revenue Growth (YoY)
-62.28%-51.37%8.98%89.55%14.05%26.45%
Cost of Revenue
2.653.837.149.878.094.76
Gross Profit
6.2413.4428.3822.739.110.32
Selling, General & Admin
19.8226.9328.7420.8915.9517.51
Other Operating Expenses
0.49-1.74-0.550.030.08
Operating Expenses
20.4127.0330.5820.416.0117.61
Operating Income
-14.17-13.59-2.22.33-6.91-7.29
Interest Expense
-0.01-0.03-0.03--0.01-
Interest & Investment Income
000.01---
Currency Exchange Gain (Loss)
0.410.410.41---
Other Non Operating Income (Expenses)
-0.09-----
EBT Excluding Unusual Items
-13.86-13.2-1.812.33-6.92-7.29
Asset Writedown
-9.99-9.99----
Pretax Income
-23.85-23.19-1.812.33-6.92-7.29
Net Income
-23.85-23.19-1.812.33-6.92-7.29
Net Income to Common
-23.85-23.19-1.812.33-6.92-7.29
Shares Outstanding (Basic)
242221212017
Shares Outstanding (Diluted)
242221222017
Shares Change (YoY)
11.96%1.49%-2.19%7.50%22.58%2.46%
EPS (Basic)
-0.99-1.06-0.080.11-0.34-0.44
EPS (Diluted)
-0.99-1.06-0.080.11-0.34-0.44
Free Cash Flow
-16.76-8.640.75-6.61-4.98-5.12
Free Cash Flow Per Share
-0.70-0.400.04-0.30-0.24-0.31
Gross Margin
70.23%77.82%79.90%69.73%52.94%68.45%
Operating Margin
-159.49%-78.67%-6.20%7.15%-40.18%-48.34%
Profit Margin
-268.44%-134.29%-5.09%7.15%-40.26%-48.34%
Free Cash Flow Margin
-188.64%-50.02%2.12%-20.27%-28.93%-33.93%
EBITDA
-14.08-13.49-2.12.39-6.88-7.27
EBITDA Margin
-158.45%-78.12%-5.92%7.32%-40.00%-48.24%
D&A For EBITDA
0.090.10.10.060.030.01
EBIT
-14.17-13.59-2.22.33-6.91-7.29
EBIT Margin
-159.49%-78.67%-6.20%7.15%-40.18%-48.34%
Revenue as Reported
9.2117.6935.9333.3317.2615.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.